Not available
Quote | Pharming Group Nv Ord (OTCMKTS:PHGUF)
Last: | $1.20 |
---|---|
Change Percent: | 1.67% |
Open: | $1.18 |
Close: | $1.20 |
High: | $1.2 |
Low: | $1.18 |
Volume: | 400 |
Last Trade Date Time: | 03/11/2024 03:00:00 am |
News | Pharming Group Nv Ord (OTCMKTS:PHGUF)
2024-03-14 13:15:03 ET Pharming Group N.V. (PHAR) Q4 2023 Earnings Conference Call March 14, 2024 08:30 AM ET Company Participants Sijmen de Vries - Chief Executive Officer Stephen Toor - Chief Commercial Officer Anurag Relan - Chief Medical Officer Jeroen Wa...
Full year 2023 total revenues increased by 19% to US$245.3 million Record fourth quarter RUCONEST® revenues of US$73.3 million resulted in a 10% increase in full year 2023 RUCONEST® revenues to US$227.1 million Strong start to Joenja® (leniolisib) launch with 81...
Message Board Posts | Pharming Group Nv Ord (OTCMKTS:PHGUF)
Subject | By | Source | When |
---|---|---|---|
Get up early. Short sellers of this | Matmak | investorshub | 01/28/2021 10:08:49 PM |
Nasdaq listing in December. Load up. | Futurecash | investorshub | 12/15/2020 1:58:55 PM |
Pharming Group reports interim financial results for the | nixke | investorshub | 10/25/2018 6:13:55 PM |
..."This data therefore supports additional clinical investigations for | nixke | investorshub | 10/23/2018 4:37:30 PM |
Recovery Day! | dennisv | investorshub | 03/14/2018 8:57:56 AM |
News, Short Squeeze, Breakout and More Instantly...
Pharming Group Nv Ord Company Name:
PHGUF Stock Symbol:
OTCMKTS Market:
Full year 2023 total revenues increased by 19% to US$245.3 million Record fourth quarter RUCONEST® revenues of US$73.3 million resulted in a 10% increase in full year 2023 RUCONEST® revenues to US$227.1 million Strong start to Joenja® (leniolisib) launch with 81...
Leiden, The Netherlands, February 29, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary (unaudited) fourth quarter and full year 2023 financial results, for the period ended December 31, on Thursday, March 14, 2...
Leiden, The Netherlands, February 8, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor conferences in the month of February: Oppenheimer 34 th ...